GPC3 CAR T Cells With IL-15 and IL-21 for Recurrent ATRT and CNS Rhabdoid Tumors (RADIANT)

Clinical trial NCT07513194 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07513194
Sponsor: Baylor College of Medicine
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Atypical Teratoid Rhabdoid Tumor Central Nervous System Rhabdoid Tumor

Start date: 2026-09-01
Primary completion: 2029-10-31
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.